Modus Therapeutics Holding AB (MODTX) — Cash Flow-to-Debt Ratio
Modus Therapeutics Holding AB (MODTX) has a Cash Flow-to-Debt Ratio of -1.38x as of December 2025, meaning its operating cash flow of Skr-5.00 Million could theoretically repay -1% of its total liabilities (Skr3.62 Million) in one year. See MODTX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Modus Therapeutics Holding AB Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Modus Therapeutics Holding AB across 8 annual periods. Also explore Modus Therapeutics Holding AB (MODTX) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Modus Therapeutics Holding AB (2018–2025)
Year-by-year debt coverage analysis for Modus Therapeutics Holding AB. For market capitalisation and broader financial context, see Modus Therapeutics Holding AB (MODTX) total market value.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.00x | Skr-18.07 Million | Skr3.62 Million | ▲ +6.4% |
| 2024 | -5.34x | Skr-14.68 Million | Skr2.75 Million | ▲ +24.4% |
| 2023 | -7.07x | Skr-16.68 Million | Skr2.36 Million | ▼ -351.1% |
| 2022 | -1.57x | Skr-21.72 Million | Skr13.86 Million | ▲ +46.8% |
| 2021 | -2.95x | Skr-16.08 Million | Skr5.46 Million | ▲ +79.8% |
| 2020 | -14.58x | Skr-7.23 Million | Skr496.00K | ▼ -57.3% |
| 2019 | -9.27x | Skr-43.90 Million | Skr4.74 Million | ▼ -433.2% |
| 2018 | -1.74x | Skr-40.06 Million | Skr23.05 Million | — |